エピソード

  • Karen C. Daily, D.O. - RiskReady: A Systems Approach to Improving the Recognition and Treatment of High-Risk, HR+, HER2- Early Breast Cancer

    Karen C. Daily, D.O. - RiskReady: A Systems Approach to Improving the Recognition and Treatment of High-Risk, HR+, HER2- Early Breast Cancer
    2025/12/12
    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

    For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/BWD865. CME/MOC/NCPD/CPE/AAPA credit will be available until November 30, 2026.

    RiskReady: A Systems Approach to Improving the Recognition and Treatment of High-Risk, HR+, HER2- Early Breast Cancer

    The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.

    In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Support
    This activity is supported by an educational grant from Lilly.

    Disclosure information is available at the beginning of the video presentation.

    続きを読む 一部表示
    40 分
  • Lynsey P. Teulings, APRN - Ahead of the Immunotherapy Curve in Head and Neck Cancer: Preparing for Expanding Immune Options in Locally Advanced and Recurrent/Metastatic Disease

    Lynsey P. Teulings, APRN - Ahead of the Immunotherapy Curve in Head and Neck Cancer: Preparing for Expanding Immune Options in Locally Advanced and Recurrent/Metastatic Disease
    2025/12/12
    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

    For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RMT865. CME/NCPD/CPE/AAPA/IPCE credit will be available until November 25, 2026.

    Ahead of the Immunotherapy Curve in Head and Neck Cancer: Preparing for Expanding Immune Options in Locally Advanced and Recurrent/Metastatic Disease

    In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Support
    This activity is supported through educational grants from Bristol Myers Squibb and Johnson & Johnson.

    Disclosure information is available at the beginning of the video presentation.

    続きを読む 一部表示
    1 時間 8 分
  • Susana Banerjee, MBBS, MA, FRCP, PhD, Ana Oaknin, MD, PhD - Putting the Puzzle Together in Advanced Ovarian and Cervical Cancers: Translating Evidence Into Practice for Approved and Emerging ADCs

    Susana Banerjee, MBBS, MA, FRCP, PhD, Ana Oaknin, MD, PhD - Putting the Puzzle Together in Advanced Ovarian and Cervical Cancers: Translating Evidence Into Practice for Approved and Emerging ADCs
    2025/12/05
    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

    For the full presentation, downloadable Practice Aids, slides, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/WMS865. EBAC/CME credit will be available until December 2, 2026.

    Putting the Puzzle Together in Advanced Ovarian and Cervical Cancers: Translating Evidence Into Practice for Approved and Emerging ADCs

    In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Support
    This activity is supported by an independent educational grant from Genmab.

    Disclosure information is available at the beginning of the video presentation.

    続きを読む 一部表示
    37 分
  • Professor Stephen Johnston, MA, FRCP, PhD - Charting New Paths in the Treatment of ER+, HER2- MBC: Seeking Clarity and Consensus Through Evidence-Aligned Clinical Cases

    Professor Stephen Johnston, MA, FRCP, PhD - Charting New Paths in the Treatment of ER+, HER2- MBC: Seeking Clarity and Consensus Through Evidence-Aligned Clinical Cases
    2025/12/03
    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

    For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SGD865. CME/MOC/EBAC/NCPD/CPE/AAPA/IPCE credit will be available until December 12, 2026.

    Charting New Paths in the Treatment of ER+, HER2- MBC: Seeking Clarity and Consensus Through Evidence-Aligned Clinical Cases

    In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Support
    This activity is supported by an educational grant from Lilly.

    Disclosure information is available at the beginning of the video presentation.

    続きを読む 一部表示
    1 時間 11 分
  • Erica L. Mayer, MD, MPH - Nurturing Lasting Benefits of Adjuvant CDK4/6 Inhibitor Therapy in High-Risk HR+, HER2- EBC: Best Practices for Patient Education, AE Monitoring and Management, and Enhanced Adherence/Persistence

    Erica L. Mayer, MD, MPH - Nurturing Lasting Benefits of Adjuvant CDK4/6 Inhibitor Therapy in High-Risk HR+, HER2- EBC: Best Practices for Patient Education, AE Monitoring and Management, and Enhanced Adherence/Persistence
    2025/12/03
    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

    For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/DTQ865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until November 25, 2026.

    Nurturing Lasting Benefits of Adjuvant CDK4/6 Inhibitor Therapy in High-Risk HR+, HER2- EBC: Best Practices for Patient Education, AE Monitoring and Management, and Enhanced Adherence/Persistence

    In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Support
    This activity is supported by an educational grant from Lilly.

    Disclosure information is available at the beginning of the video presentation.

    続きを読む 一部表示
    22 分
  • Angela Lamarca, MD, PhD, MSc - The Power of Personalised Approaches in Advanced CCA: Team-Based Strategies to Individualise Clinical Care

    Angela Lamarca, MD, PhD, MSc - The Power of Personalised Approaches in Advanced CCA: Team-Based Strategies to Individualise Clinical Care
    2025/12/03
    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

    For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/NJR865. CME credit will be available until 2 November 2026.

    The Power of Personalised Approaches in Advanced CCA: Team-Based Strategies to Individualise Clinical Care

    In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Support
    This activity is supported by an educational grant from Servier.

    Disclosure information is available at the beginning of the video presentation.

    続きを読む 一部表示
    35 分
  • Susana Banerjee, MBBS, MA, FRCP, PhD, Kathleen N. Moore, MD, MS - Harnessing the Power of ADCs in Gynecologic Cancers: Expert Insights for Practice Integration

    Susana Banerjee, MBBS, MA, FRCP, PhD, Kathleen N. Moore, MD, MS - Harnessing the Power of ADCs in Gynecologic Cancers: Expert Insights for Practice Integration
    2025/12/03
    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

    For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAD865. CME/MOC/AAPA credit will be available until November 20, 2026.

    Harnessing the Power of ADCs in Gynecologic Cancers: Expert Insights for Practice Integration

    In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Support
    This activity is supported by independent educational grants from AstraZeneca, Daiichi Sankyo, Inc., and Gilead Sciences, Inc.

    Disclosure information is available at the beginning of the video presentation.

    続きを読む 一部表示
    38 分
  • Erica L. Mayer, MD, MPH - Risk Assessment and Treatment Initiation: Successfully Jumpstarting the Adjuvant CDK4/6 Inhibitor Treatment Journey in HR+, HER2- EBC

    Erica L. Mayer, MD, MPH - Risk Assessment and Treatment Initiation: Successfully Jumpstarting the Adjuvant CDK4/6 Inhibitor Treatment Journey in HR+, HER2- EBC
    2025/12/03
    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

    For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ARM865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until November 20, 2026.

    Risk Assessment and Treatment Initiation: Successfully Jumpstarting the Adjuvant CDK4/6 Inhibitor Treatment Journey in HR+, HER2- EBC

    In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Support
    This activity is supported by an educational grant from Lilly.

    Disclosure information is available at the beginning of the video presentation.

    続きを読む 一部表示
    27 分